Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noel Smith

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Arthritis Care & Research|February 17, 2016
Defining an International Standard Set of Outcome Measures for Patients With Hip or Knee Osteoarthritis: Consensus of the International Consortium for Health Outcomes Measurement Hip and Knee Osteoarthritis Working GroupOla Rolfson, Stephanie Wissig, Lisa van Maasakkers, et al.
Mabs|April 4, 2025
Proceedings of the 15<sup>th</sup> European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Karien Bloem, Lysie Champion, et al.
The AAPS Journal|February 12, 2026
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug ProductsJennifer K Lee, Ha-Na Lee, Sudhir Agrawal, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Arthritis Care & Research|February 17, 2016
Defining an International Standard Set of Outcome Measures for Patients With Hip or Knee Osteoarthritis: Consensus of the International Consortium for Health Outcomes Measurement Hip and Knee Osteoarthritis Working GroupOla Rolfson, Stephanie Wissig, Lisa van Maasakkers, et al.
Mabs|April 4, 2025
Proceedings of the 15<sup>th</sup> European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Karien Bloem, Lysie Champion, et al.
The AAPS Journal|February 12, 2026
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug ProductsJennifer K Lee, Ha-Na Lee, Sudhir Agrawal, et al.
Pageof 3